US 12180211
Compounds, compositions and methods
granted A61PA61P1/04A61P17/02
Quick answer
US patent 12180211 (Compounds, compositions and methods) held by DENALI THERAPEUTICS INC. expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P1/04, A61P17/02, A61P17/06, A61P19/02